Nuo Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nuo Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q3 2024.
  • Nuo Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 45.6M shares, a 8.24% increase year-over-year.
  • Nuo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 42.1M shares, a 5.19% increase from 2022.
  • Nuo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 40M shares, a 32% increase from 2021.
  • Nuo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 30.3M shares, a 17.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 45.6M +3.47M +8.24% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 44.7M +2.86M +6.84% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 44.2M +2.44M +5.84% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 42.1M +2.08M +5.19% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-19
Q3 2023 42.1M +1.01M +2.45% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 41.8M +2.02M +5.08% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 41.8M +4.67M +12.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 40M +9.7M +32% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-19
Q3 2022 41.1M +10.9M +35.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 39.8M +9.52M +31.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 37.1M +6.87M +22.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 30.3M +4.6M +17.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 30.3M +6.01M +24.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 30.3M +6.01M +24.8% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-10
Q1 2021 30.3M +6.3M +26.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 25.7M +1.97M +8.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 24.2M +525K +2.21% Jul 1, 2020 Sep 30, 2020 10-Q 2022-11-04
Q2 2020 24.2M +525K +2.21% Apr 1, 2020 Jun 30, 2020 10-K 2022-04-15
Q1 2020 24M +240K +1.01% Jan 1, 2020 Mar 31, 2020 10-K 2022-04-15
Q4 2019 23.7M +444K +1.91% Oct 1, 2019 Dec 31, 2019 10-K 2022-04-15
Q3 2019 23.7M 0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-01-31
Q2 2019 23.7M +791K +3.45% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-19
Q1 2019 23.7M +1M +4.4% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-20
Q4 2018 23.3M +8.63M +58.9% Oct 1, 2018 Dec 31, 2018 10-K 2019-04-16
Q3 2018 23.7M +7.87M +49.6% Jul 1, 2018 Sep 30, 2018 10-Q 2020-01-31
Q2 2018 22.9M +13M +131% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 22.7M +12.8M +129% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 14.6M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 15.9M +5.93M +59.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 9.93M +133K +1.36% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 9.93M -116M -92.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 9.93M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 9.79M -116M -92.2% May 5, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 126M 0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2016-10-24
Q2 2015 126M +4.31M +3.55% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 126M +14.7M +13.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-10-24
Q2 2014 122M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 111M +12.1M +12.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q1 2013 99.1M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.